Asia-Pacific qPCR Market
完整報告名稱與涵蓋範圍
Asia-Pacific qPCR Market Research Report Information by Product & Services (Product & Services), by Application (Clinical, RUO, and Forensic), by Disease Type (Newborn Diseases, Respiratory, STI, Oncology, Gastroenteritis, Tropical Diseases, Herpes Virus Infections, Others), by End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others) Forecast to 2032
報告摘要
Asia-Pacific qPCR Market Research Report Information by Product & Services (Product & Services), by Application (Clinical, RUO, and Forensic), by Disease Type (Newborn Diseases, Respiratory, STI, Oncology, Gastroenteritis, Tropical Diseases, Herpes Virus Infections, Others), by End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others) Forecast to 2032
Market Overview
Asia-Pacific qPCR Market is anticipated to register a significant market expansion at a CAGR of 8.23% during the review period. Quantitative polymerase chain reaction (qPCR) is a molecular biology technique used to amplify and quantify DNA molecules. It is a highly sensitive method for detecting and measuring the amount of a specific DNA sequence in a sample. qPCR involves the use of fluorescent dyes or probes that bind to the amplified DNA during the reaction. The fluorescence emitted during amplification is monitored in real-time, allowing for the quantification of the initial amount of DNA present in the sample. This technique is widely used in various applications such as gene expression analysis, pathogen detection, and genetic testing.
The increasing incidences of various diseases across Asia-Pacific and technological advancements in qPCR products are fueling the growth of the qPCR market. Additionally, the high cost associated with qPCR solutions is a restraining factor for the market. However, the increasing funding for genomic research will provide growth opportunities for the market in the future.
Market Segmentation
Based on Product & Services, the Asia-Pacific qPCR Market has been segmented into Product and Services.
Based on application, the Asia-Pacific qPCR Market has been segmented into clinical, RUO, and forensic.
The Market has been segmented, based on disease type Newborn Diseases, Respiratory, STI, Oncology, Gastroenteritis, Tropical Diseases, Herpes Virus Infections, Others.
The Asia-Pacific qPCR Market has been segmented, based on End User, Hospitals & Clinics, Diagnostic Centers & Laboratories, Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others.
The Market accounted for USD 8,269.28 million in 2023 and is projected to grow at a CAGR of 8.23% during the forecast period. Asia-Pacific is further segmented into the China, India, Japan, South Korea, Australia, Taiwan, Hong Kong, and Rest of Asia-Pacific.
Major Players
Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthineers AG, QIAGEN N.V., Eurofins Scientific, and Danaher Corporation.
授權報價
| Single User Price | $2,950 USD |
| Multi User Licence (up to 10 users) | $3,950 USD |
| Enterprisewide Price (Global Site License) | $5,250 USD |
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 17
2 MARKET INTRODUCTION 19
2.1 DEFINITION 19
2.2 SCOPE OF THE STUDY 19
2.3 RESEARCH OBJECTIVE 19
2.4 MARKET STRUCTURE 20
3 RESEARCH METHODOLOGY 21
3.1 OVERVIEW 21
3.2 DATA FLOW 23
3.2.1 DATA MINING PROCESS 23
3.3 PURCHASED DATABASE: 24
3.4 SECONDARY SOURCES: 25
3.4.1 SECONDARY RESEARCH DATA FLOW: 26
3.5 PRIMARY RESEARCH: 27
3.5.1 PRIMARY RESEARCH DATA FLOW: 28
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 29
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 29
3.6.1 REVENUE ANALYSIS APPROACH 29
3.7 DATA FORECASTING 30
3.7.1 DATA FORECASTING TYPE 30
3.8 DATA MODELING 31
3.8.1 MICROECONOMIC FACTOR ANALYSIS: 31
3.8.2 DATA MODELING: 32
3.9 TEAMS AND ANALYST CONTRIBUTION 34
4 MARKET DYNAMICS 36
4.1 INTRODUCTION 36
4.2 DRIVERS 37
4.2.1 INCREASING INCIDENCES OF VARIOUS DISEASES ACROSS ASIA-PACIFIC 37
4.2.2 TECHNOLOGICAL ADVANCEMENTS IN QPCR PRODUCTS 37
4.3 RESTRAINTS 39
4.3.1 HIGH COST ASSOCIATED WITH QPCR SOLUTION 39
4.4 OPPORTUNITY 40
4.4.1 INCREASING FUNDING FOR GENOMIC RESEARCH 40
5 MARKET FACTOR ANALYSIS 41
5.1 VALUE CHAIN ANALYSIS 41
5.1.1 R&D 42
5.1.2 MANUFACTURING 42
5.1.3 DISTRIBUTION AND SALES 43
5.1.4 POST-SALES MONITORING 43
5.2 PORTER’S FIVE FORCES MODEL 44
5.2.1 THREAT OF NEW ENTRANTS 44
5.2.2 BARGAINING POWER OF SUPPLIERS 44
5.2.3 THREAT OF SUBSTITUTES 45
5.2.4 BARGAINING POWER OF BUYERS 45
5.2.5 INTENSITY OF RIVALRY 45
5.3 IMPACT OF COVID-19 ON THE ASIA-PACIFIC QPCR MARKET 46
5.3.1 IMPACT ON SUPPLY CHAIN 46
5.3.2 IMPACT ON DEMAND AND SUPPLY 46
6 ASIA-PACIFIC QPCR MARKET, BY PRODUCT & SERVICES 48
6.1 OVERVIEW 48
6.2 PRODUCT 50
6.3 SERVICES 51
7 ASIA-PACIFIC QPCR MARKET, BY APPLICATION 52
7.1 OVERVIEW 52
7.2 CLINICAL 54
7.3 RUO 55
7.4 FORENSIC 55
8 ASIA-PACIFIC QPCR MARKET, BY DISEASE TYPE 56
8.1 NEW BORN DISEASES 59
8.2 RESPIRATORY 60
8.3 STI 61
8.4 ONCOLOGY 62
8.5 GASTROENTERITIS 63
8.6 TROPICAL DISEASES 64
8.7 HERPES VIRUS INFECTIONS 65
8.8 OTHERS 66
9 ASIA-PACIFIC QPCR MARKET, BY END USER 67
9.1 OVERVIEW 67
9.2 DIAGNOSTIC CENTERS & LABORATORIES 70
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 71
9.4 FORENSIC LABORATORIES 71
9.5 OTHERS 72
10 ASIA-PACIFIC QPCR MARKET, BY COUNTRY 73
10.1 OVERVIEW 73
10.1.1 CHINA 81
10.1.2 INDIA 87
10.1.3 JAPAN 93
10.1.4 SOUTH KOREA 98
10.1.5 AUSTRALIA 104
10.1.6 TAIWAN 110
10.1.7 HONG KONG 116
10.1.8 REST OF ASIA-PACIFIC 122
11 COMPETITIVE LANDSCAPE 130
11.1 INTRODUCTION 130
11.2 MARKET SHARE ANALYSIS FOR PRODUCTS, 2023 130
11.3 MARKET SHARE ANALYSIS FOR SERVICE, 2023 131
11.4 COMPETITOR DASHBOARD 132
11.5 PUBLIC PLAYERS STOCK SUMMARY 133
11.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 133
12 COMPETITIVE LANDSCAPE 134
12.1 THERMO FISHER SCIENTIFIC, INC. 134
12.1.1 COMPANY OVERVIEW 134
12.1.2 FINANCIAL OVERVIEW 135
12.1.3 PRODUCTS OFFERED 136
12.1.4 KEY DEVELOPMENTS 136
12.1.5 SWOT ANALYSIS 137
12.1.6 KEY STRATEGIES 137
12.2 SIEMENS HEALTHINEERS AG 138
12.2.1 COMPANY OVERVIEW 138
12.2.2 FINANCIAL OVERVIEW 139
12.2.3 PRODUCTS OFFERED 140
12.2.4 KEY DEVELOPMENTS 140
12.2.5 SWOT ANALYSIS 140
12.2.6 KEY STRATEGIES 141
12.3 ABBOTT 142
12.3.1 COMPANY OVERVIEW 142
12.3.2 FINANCIAL OVERVIEW 143
12.3.3 PRODUCTS OFFERED 144
12.3.4 KEY DEVELOPMENTS 144
12.3.5 SWOT ANALYSIS 144
12.3.6 KEY STRATEGIES 145
12.4 F. HOFFMANN-LA ROCHE LTD 146
12.4.1 COMPANY OVERVIEW 146
12.4.2 FINANCIAL OVERVIEW 147
12.4.3 PRODUCTS OFFERED 148
12.4.4 KEY DEVELOPMENTS 148
12.4.5 SWOT ANALYSIS 149
12.4.6 KEY STRATEGIES 149
12.5 BGI GENOMICS 150
12.5.1 COMPANY OVERVIEW 150
12.5.2 FINANCIAL OVERVIEW 150
12.5.3 SERVICES OFFERED 150
12.5.4 KEY DEVELOPMENTS 151
12.5.5 SWOT ANALYSIS 151
12.5.6 KEY STRATEGIES 151
12.6 EUROFINS SCIENTIFIC 152
12.6.1 COMPANY OVERVIEW 152
12.6.2 FINANCIAL OVERVIEW 153
12.6.3 SERVICES OFFERED 153
12.6.4 KEY DEVELOPMENTS 154
12.6.5 SWOT ANALYSIS 154
12.6.6 KEY STRATEGIES 154
12.7 QIAGEN N.V. 155
12.7.1 COMPANY OVERVIEW 155
12.7.2 FINANCIAL OVERVIEW 156
12.7.3 SERVICES OFFERED 156
12.7.4 KEY DEVELOPMENTS 157
12.7.5 SWOT ANALYSIS 157
12.7.6 KEY STRATEGIES 157
12.8 DANAHER CORPORATION 158
12.8.1 COMPANY OVERVIEW 158
12.8.2 FINANCIAL OVERVIEW 159
12.8.3 PRODUCTS OFFERED 160
12.8.4 KEY DEVELOPMENTS 161
12.8.5 SWOT ANALYSIS 161
12.8.6 KEY STRATEGIES 161
12.9 GENEWIZ, INC. 162
12.9.1 COMPANY OVERVIEW 162
12.9.2 FINANCIAL OVERVIEW 162
12.9.3 SERVICES OFFERED 163
12.9.4 KEY DEVELOPMENTS 163
12.9.5 SWOT ANALYSIS 163
12.9.6 KEY STRATEGIES 164
12.10 1ST BASE 165
12.10.1 COMPANY OVERVIEW 165
12.10.2 FINANCIAL OVERVIEW 165
12.10.3 SERVICES OFFERED 165
12.10.4 KEY DEVELOPMENTS 165
12.10.5 SWOT ANALYSIS 166
12.10.6 KEY STRATEGIES 166
13 DATA CITATIONS 167
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 32
TABLE 2 ASIA-PACIFIC QPCR MARKET, BY PRODUCT & SERVICES, 2019–2032 (USD MILLION) 49
TABLE 3 ASIA-PACIFIC QPCR MARKET, FOR PRODUCTS BY COUNTRY, 2019–2032 (USD MILLION) 50
TABLE 4 ASIA-PACIFIC QPCR MARKET, FOR PRODUCT, BY TYPE 2019–2032 (USD MILLION) 51
TABLE 5 ASIA-PACIFIC QPCR MARKET, FOR SERVICES BY COUNTRY, 2019–2032 (USD MILLION) 51
TABLE 6 ASIA-PACIFIC QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 53
TABLE 7 ASIA-PACIFIC QPCR MARKET, FOR CLINICAL, BY COUNTRY, 2019–2032 (USD MILLION) 54
TABLE 8 ASIA-PACIFIC QPCR MARKET, FOR RUO BY COUNTRY, 2019–2032 (USD MILLION) 55
TABLE 9 ASIA-PACIFIC QPCR MARKET, FOR FORENSIC BY COUNTRY, 2019–2032 (USD MILLION) 55
TABLE 10 ASIA-PACIFIC QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 58
TABLE 11 ASIA-PACIFIC QPCR MARKET, FOR NEW BORN DISEASES BY COUNTRY, 2019–2032 (USD MILLION) 59
TABLE 12 ASIA-PACIFIC QPCR MARKET, FOR NEW BORN DISEASES BY TYPE, 2019–2032 (USD MILLION) 60
TABLE 13 ASIA-PACIFIC QPCR MARKET, FOR RESPIRATORY BY COUNTRY, 2019–2032 (USD MILLION) 60
TABLE 14 ASIA-PACIFIC QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 61
TABLE 15 ASIA-PACIFIC QPCR MARKET, FOR STI BY COUNTRY, 2019–2032 (USD MILLION) 61
TABLE 16 ASIA-PACIFIC QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 62
TABLE 17 ASIA-PACIFIC QPCR MARKET, FOR ONCOLOGY, BY COUNTRY, 2019–2032 (USD MILLION) 62
TABLE 18 ASIA-PACIFIC QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 63
TABLE 19 ASIA-PACIFIC QPCR MARKET, FOR GASTROENTERITIS BY COUNTRY, 2019–2032 (USD MILLION) 63
TABLE 20 ASIA-PACIFIC QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 64
TABLE 21 ASIA-PACIFIC QPCR MARKET, FOR TROPICAL DISEASES BY COUNTRY, 2019–2032 (USD MILLION) 64
TABLE 22 ASIA-PACIFIC QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 65
TABLE 23 ASIA-PACIFIC QPCR MARKET, FOR HERPES VIRUS INFECTIONS BY COUNTRY, 2019–2032 (USD MILLION) 65
TABLE 24 ASIA-PACIFIC QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 66
TABLE 25 ASIA-PACIFIC QPCR MARKET, FOR OTHERS BY COUNTRY, 2019–2032 (USD MILLION) 66
TABLE 26 ASIA-PACIFIC QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 69
TABLE 27 ASIA-PACIFIC QPCR MARKET, FOR HOSPITALS & CLINICS BY COUNTRY, 2019–2032 (USD MILLION) 70
TABLE 28 ASIA-PACIFIC QPCR MARKET, FOR DIAGNOSTIC CENTERS & LABORATORIES, BY COUNTRY, 2019–2032 (USD MILLION) 70
TABLE 29 ASIA-PACIFIC QPCR MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2032 (USD MILLION) 71
TABLE 30 ASIA-PACIFIC QPCR MARKET, FOR FORENSIC LABORATORIES, BY COUNTRY, 2019–2032 (USD MILLION) 71
TABLE 31 ASIA-PACIFIC QPCR MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (USD MILLION) 72
TABLE 32 ASIA-PACIFIC: QPCR MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 75
TABLE 33 ASIA-PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD MILLION) 76
TABLE 34 ASIA-PACIFIC: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019–2032 (USD MILLION) 76
TABLE 35 ASIA-PACIFIC: QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 76
TABLE 36 ASIA-PACIFIC: QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 77
TABLE 37 ASIA-PACIFIC: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019–2032 (USD MILLION) 77
TABLE 38 ASIA-PACIFIC: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 78
TABLE 39 ASIA-PACIFIC: QPCR MARKET, FOR STI, BY TYPE, 2019–2032 (USD MILLION) 78
TABLE 40 ASIA-PACIFIC: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 79
TABLE 41 ASIA-PACIFIC: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 79
TABLE 42 ASIA-PACIFIC: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 80
TABLE 43 ASIA-PACIFIC: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 80
TABLE 44 ASIA-PACIFIC: QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 81
TABLE 45 CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD MILLION) 81
TABLE 46 CHINA: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019–2032 (USD MILLION) 82
TABLE 47 CHINA: QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 82
TABLE 48 CHINA: QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 83
TABLE 49 CHINA: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019–2032 (USD MILLION) 83
TABLE 50 CHINA: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 84
TABLE 51 CHINA: QPCR MARKET, FOR STI, BY TYPE, 2019–2032 (USD MILLION) 84
TABLE 52 CHINA: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 85
TABLE 53 CHINA: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 85
TABLE 54 CHINA: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 86
TABLE 55 CHINA: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 86
TABLE 56 CHINA: QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 87
TABLE 57 INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD MILLION) 87
TABLE 58 INDIA: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019–2032 (USD MILLION) 87
TABLE 59 INDIA: QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 88
TABLE 60 INDIA: QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 88
TABLE 61 INDIA: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019–2032 (USD MILLION) 89
TABLE 62 INDIA: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 89
TABLE 63 INDIA: QPCR MARKET, FOR STI, BY TYPE, 2019–2032 (USD MILLION) 90
TABLE 64 INDIA: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 90
TABLE 65 INDIA: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 91
TABLE 66 INDIA: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 91
TABLE 67 INDIA: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 92
TABLE 68 INDIA: QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 92
TABLE 69 JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD MILLION) 93
TABLE 70 JAPAN: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019–2032 (USD MILLION) 93
TABLE 71 JAPAN: QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 93
TABLE 72 JAPAN: QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 94
TABLE 73 JAPAN: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019–2032 (USD MILLION) 94
TABLE 74 JAPAN: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 95
TABLE 75 JAPAN: QPCR MARKET, FOR STI, BY TYPE, 2019–2032 (USD MILLION) 95
TABLE 76 JAPAN: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 96
TABLE 77 JAPAN: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 96
TABLE 78 JAPAN: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 97
TABLE 79 JAPAN: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 97
TABLE 80 JAPAN: QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 98
TABLE 81 SOUTH KOREA: QPCR MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD MILLION) 98
TABLE 82 SOUTH KOREA: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019–2032 (USD MILLION) 99
TABLE 83 SOUTH KOREA: QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 99
TABLE 84 SOUTH KOREA: QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 100
TABLE 85 SOUTH KOREA: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019–2032 (USD MILLION) 100
TABLE 86 SOUTH KOREA: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 101
TABLE 87 SOUTH KOREA: QPCR MARKET, FOR STI, BY TYPE, 2019–2032 (USD MILLION) 101
TABLE 88 SOUTH KOREA: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 102
TABLE 89 SOUTH KOREA: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 102
TABLE 90 SOUTH KOREA: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 103
TABLE 91 SOUTH KOREA: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 103
TABLE 92 SOUTH KOREA: QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 104
TABLE 93 AUSTRALIA: QPCR MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD MILLION) 104
TABLE 94 AUSTRALIA: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019–2032 (USD MILLION) 105
TABLE 95 AUSTRALIA: QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 105
TABLE 96 AUSTRALIA: QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 106
TABLE 97 AUSTRALIA: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019–2032 (USD MILLION) 106
TABLE 98 AUSTRALIA: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 107
TABLE 99 AUSTRALIA: QPCR MARKET, FOR STI, BY TYPE, 2019–2032 (USD MILLION) 107
TABLE 100 AUSTRALIA: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 108
TABLE 101 AUSTRALIA: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 108
TABLE 102 AUSTRALIA: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 109
TABLE 103 AUSTRALIA: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 109
TABLE 104 AUSTRALIA: QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 110
TABLE 105 TAIWAN: QPCR MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD MILLION) 110
TABLE 106 TAIWAN: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019–2032 (USD MILLION) 111
TABLE 107 TAIWAN: QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 111
TABLE 108 TAIWAN: QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 112
TABLE 109 TAIWAN: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019–2032 (USD MILLION) 112
TABLE 110 TAIWAN: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 113
TABLE 111 TAIWAN: QPCR MARKET, FOR STI, BY TYPE, 2019–2032 (USD MILLION) 113
TABLE 112 TAIWAN: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 114
TABLE 113 TAIWAN: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 114
TABLE 114 TAIWAN: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 115
TABLE 115 TAIWAN: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 115
TABLE 116 TAIWAN: QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 116
TABLE 117 HONG KONG: QPCR MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD MILLION) 116
TABLE 118 HONG KONG: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019–2032 (USD MILLION) 117
TABLE 119 HONG KONG: QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 117
TABLE 120 HONG KONG: QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 118
TABLE 121 HONG KONG: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019–2032 (USD MILLION) 118
TABLE 122 HONG KONG: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 119
TABLE 123 HONG KONG: QPCR MARKET, FOR STI, BY TYPE, 2019–2032 (USD MILLION) 119
TABLE 124 HONG KONG: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 120
TABLE 125 HONG KONG: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 120
TABLE 126 HONG KONG: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 121
TABLE 127 HONG KONG: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 121
TABLE 128 HONG KONG: QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 122
TABLE 129 REST OF ASIA-PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD MILLION) 122
TABLE 130 REST OF ASIA-PACIFIC: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019–2032 (USD MILLION) 123
TABLE 131 REST OF ASIA-PACIFIC: QPCR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 123
TABLE 132 REST OF ASIA-PACIFIC: QPCR MARKET, BY DISEASE TYPE, 2019–2032 (USD MILLION) 124
TABLE 133 REST OF ASIA-PACIFIC: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019–2032 (USD MILLION) 124
TABLE 134 REST OF ASIA-PACIFIC: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019–2032 (USD MILLION) 125
TABLE 135 REST OF ASIA-PACIFIC: QPCR MARKET, FOR STI, BY TYPE, 2019–2032 (USD MILLION) 125
TABLE 136 REST OF ASIA-PACIFIC: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019–2032 (USD MILLION) 126
TABLE 137 REST OF ASIA-PACIFIC: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019–2032 (USD MILLION) 126
TABLE 138 REST OF ASIA-PACIFIC: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019–2032 (USD MILLION) 127
TABLE 139 REST OF ASIA-PACIFIC: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019–2032 (USD MILLION) 127
TABLE 140 REST OF ASIA-PACIFIC: QPCR MARKET, BY END USER, 2019–2032 (USD MILLION) 128
TABLE 141 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED 136
TABLE 142 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED 140
TABLE 143 ABBOTT: PRODUCT OFFERED 144
TABLE 144 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 148
TABLE 145 BGI GENOMICS: SERVICES OFFERED 150
TABLE 146 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW 153
TABLE 147 EUROFINS SCIENTIFIC: SERVICES OFFERED 153
TABLE 148 QIAGEN N.V.: SERVICES OFFERED 156
TABLE 149 DANAHER CORPORATION: PRODUCTS OFFERED 160
TABLE 150 GENEWIZ, INC.: SERVICES OFFERED 163
TABLE 151 1ST BASE: SERVICES OFFERED 165
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC QPCR MARKET: STRUCTURE 20
FIGURE 2 ASIA-PACIFIC QPCR MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032) 36
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 38
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032) 39
FIGURE 5 VALUE CHAIN ANALYSIS OF THE ASIA-PACIFIC QPCR MARKET 41
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: ASIA-PACIFIC QPCR MARKET 44
FIGURE 7 ASIA-PACIFIC QPCR MARKET, PRODUCT & SERVICES SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION) 48
FIGURE 8 ASIA-PACIFIC QPCR MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION) 49
FIGURE 9 ASIA-PACIFIC QPCR MARKET SHARE (%), BY PRODUCT & SERVICES, 2023 50
FIGURE 10 ASIA-PACIFIC QPCR MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION) 52
FIGURE 11 ASIA-PACIFIC QPCR MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION) 53
FIGURE 12 ASIA-PACIFIC QPCR MARKET SHARE (%), BY TYPE, 2023 54
FIGURE 13 ASIA-PACIFIC QPCR MARKET, DISEASE TYPE SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION) 57
FIGURE 14 ASIA-PACIFIC QPCR MARKET, BY DISEASE TYPE, 2023 & 2032 (USD MILLION) 58
FIGURE 15 ASIA-PACIFIC QPCR MARKET SHARE (%), BY DISEASE TYPE, 2023 59
FIGURE 16 ASIA-PACIFIC QPCR MARKET, END USER SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION) 68
FIGURE 17 ASIA-PACIFIC QPCR MARKET, BY END USER, 2023 & 2032 (USD MILLION) 68
FIGURE 18 ASIA-PACIFIC QPCR MARKET SHARE (%), BY END USER, 2023 69
FIGURE 19 ASIA-PACIFIC MARKET ANALYSIS: QPCR MARKET, 2019-2032 (USD MILLION) 74
FIGURE 20 ASIA-PACIFIC QPCR MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION) 74
FIGURE 21 ASIA-PACIFIC QPCR MARKET SHARE, BY COUNTRY, 2023 (%) 75
FIGURE 22 ASIA-PACIFIC QPCR MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023 130
FIGURE 23 ASIA-PACIFIC QPCR MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023 131
FIGURE 24 COMPETITOR DASHBOARD: ASIA-PACIFIC QPCR MARKET 132
FIGURE 25 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT 135
FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS 137
FIGURE 27 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT 139
FIGURE 28 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS 140
FIGURE 29 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 143
FIGURE 30 ABBOTT: SWOT ANALYSIS 144
FIGURE 31 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 147
FIGURE 32 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 149
FIGURE 33 BGI GENOMICS: SWOT ANALYSIS 151
FIGURE 34 EUROFINS SCIENTIFIC: SWOT ANALYSIS 154
FIGURE 35 QIAGEN N.V.: FINANCIAL OVERVIEW SNAPSHOT 156
FIGURE 36 QIAGEN N.V.: SWOT ANALYSIS 157
FIGURE 37 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 159
FIGURE 38 DANAHER CORPORATION: SWOT ANALYSIS 161
FIGURE 39 GENEWIZ, INC.: SWOT ANALYSIS 163
FIGURE 40 1ST BASE: SWOT ANALYSIS 166
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們